Mitsui Chemicals, Inc.
MITUY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $1,809,164,000 | $1,749,743,000 | $1,879,547,000 | $1,612,688,000 |
| % Growth | 3.4% | -6.9% | 16.5% | – |
| Cost of Goods Sold | $1,420,872,000 | $1,378,946,000 | $1,498,054,000 | $1,233,948,000 |
| Gross Profit | $388,292,000 | $370,797,000 | $381,493,000 | $378,740,000 |
| % Margin | 21.5% | 21.2% | 20.3% | 23.5% |
| R&D Expenses | $0 | $0 | $43,000,000 | $38,100,000 |
| G&A Expenses | $295,352,000 | $282,657,000 | $156,166,000 | $126,949,000 |
| SG&A Expenses | $295,352,000 | $282,657,000 | $233,508,000 | $195,593,000 |
| Sales & Mktg Exp. | $0 | $0 | $77,342,000 | $68,644,000 |
| Other Operating Expenses | $14,604,000 | $14,016,000 | $8,081,000 | $5,663,000 |
| Operating Expenses | $309,956,000 | $296,673,000 | $284,589,000 | $239,356,000 |
| Operating Income | $78,336,000 | $74,124,000 | $96,904,000 | $139,384,000 |
| % Margin | 4.3% | 4.2% | 5.2% | 8.6% |
| Other Income/Exp. Net | -$6,689,000 | -$793,000 | $20,374,000 | $1,890,000 |
| Pre-Tax Income | $71,647,000 | $73,331,000 | $117,278,000 | $141,274,000 |
| Tax Expense | $29,018,000 | $19,556,000 | $27,140,000 | $22,723,000 |
| Net Income | $32,242,000 | $49,999,000 | $82,936,000 | $109,990,000 |
| % Margin | 1.8% | 2.9% | 4.4% | 6.8% |
| EPS | 85.28 | 131.5 | 215.59 | 282.73 |
| % Growth | -35.1% | -39% | -23.7% | – |
| EPS Diluted | 85.28 | 131.5 | 215.59 | 282.73 |
| Weighted Avg Shares Out | 378,074 | 380,242 | 769,398 | 778,066 |
| Weighted Avg Shares Out Dil | 378,074 | 380,242 | 769,398 | 778,066 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8,013,000 | $13,870,000 | $5,678,000 | $6,175,000 |
| Interest Expense | $14,702,000 | $14,663,000 | $17,398,000 | $12,211,000 |
| Depreciation & Amortization | $99,768,000 | $95,249,000 | $92,080,000 | $84,222,000 |
| EBITDA | $186,117,000 | $183,243,000 | $182,808,000 | $216,985,000 |
| % Margin | 10.3% | 10.5% | 9.7% | 13.5% |